298 related articles for article (PubMed ID: 24681059)
1. Increased mitochondrial fission and neuronal dysfunction in Huntington's disease: implications for molecular inhibitors of excessive mitochondrial fission.
Reddy PH
Drug Discov Today; 2014 Jul; 19(7):951-5. PubMed ID: 24681059
[TBL] [Abstract][Full Text] [Related]
2. S-nitrosylation of dynamin-related protein 1 mediates mutant huntingtin-induced mitochondrial fragmentation and neuronal injury in Huntington's disease.
Haun F; Nakamura T; Shiu AD; Cho DH; Tsunemi T; Holland EA; La Spada AR; Lipton SA
Antioxid Redox Signal; 2013 Oct; 19(11):1173-84. PubMed ID: 23641925
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of mitochondrial fragmentation diminishes Huntington's disease-associated neurodegeneration.
Guo X; Disatnik MH; Monbureau M; Shamloo M; Mochly-Rosen D; Qi X
J Clin Invest; 2013 Dec; 123(12):5371-88. PubMed ID: 24231356
[TBL] [Abstract][Full Text] [Related]
4. Mutant huntingtin binds the mitochondrial fission GTPase dynamin-related protein-1 and increases its enzymatic activity.
Song W; Chen J; Petrilli A; Liot G; Klinglmayr E; Zhou Y; Poquiz P; Tjong J; Pouladi MA; Hayden MR; Masliah E; Ellisman M; Rouiller I; Schwarzenbacher R; Bossy B; Perkins G; Bossy-Wetzel E
Nat Med; 2011 Mar; 17(3):377-82. PubMed ID: 21336284
[TBL] [Abstract][Full Text] [Related]
5. Mutant huntingtin's interaction with mitochondrial protein Drp1 impairs mitochondrial biogenesis and causes defective axonal transport and synaptic degeneration in Huntington's disease.
Shirendeb UP; Calkins MJ; Manczak M; Anekonda V; Dufour B; McBride JL; Mao P; Reddy PH
Hum Mol Genet; 2012 Jan; 21(2):406-20. PubMed ID: 21997870
[TBL] [Abstract][Full Text] [Related]
6. Drp1 phosphorylation by MAPK1 causes mitochondrial dysfunction in cell culture model of Huntington's disease.
Roe AJ; Qi X
Biochem Biophys Res Commun; 2018 Feb; 496(2):706-711. PubMed ID: 29397067
[TBL] [Abstract][Full Text] [Related]
7. Mitochondrial loss, dysfunction and altered dynamics in Huntington's disease.
Kim J; Moody JP; Edgerly CK; Bordiuk OL; Cormier K; Smith K; Beal MF; Ferrante RJ
Hum Mol Genet; 2010 Oct; 19(20):3919-35. PubMed ID: 20660112
[TBL] [Abstract][Full Text] [Related]
8. Could successful (mitochondrial) networking help prevent Huntington's disease?
Oliveira JM; Lightowlers RN
EMBO Mol Med; 2010 Dec; 2(12):487-9. PubMed ID: 21117121
[TBL] [Abstract][Full Text] [Related]
9. Mutant huntingtin, abnormal mitochondrial dynamics, defective axonal transport of mitochondria, and selective synaptic degeneration in Huntington's disease.
Reddy PH; Shirendeb UP
Biochim Biophys Acta; 2012 Feb; 1822(2):101-10. PubMed ID: 22080977
[TBL] [Abstract][Full Text] [Related]
10. Dynamin-related protein 1 and mitochondrial fragmentation in neurodegenerative diseases.
Reddy PH; Reddy TP; Manczak M; Calkins MJ; Shirendeb U; Mao P
Brain Res Rev; 2011 Jun; 67(1-2):103-18. PubMed ID: 21145355
[TBL] [Abstract][Full Text] [Related]
11. Effects of overexpression of huntingtin proteins on mitochondrial integrity.
Wang H; Lim PJ; Karbowski M; Monteiro MJ
Hum Mol Genet; 2009 Feb; 18(4):737-52. PubMed ID: 19039036
[TBL] [Abstract][Full Text] [Related]
12. Drp1/Fis1-mediated mitochondrial fragmentation leads to lysosomal dysfunction in cardiac models of Huntington's disease.
Joshi AU; Ebert AE; Haileselassie B; Mochly-Rosen D
J Mol Cell Cardiol; 2019 Feb; 127():125-133. PubMed ID: 30550751
[TBL] [Abstract][Full Text] [Related]
13. Raft-like microdomains play a key role in mitochondrial impairment in lymphoid cells from patients with Huntington's disease.
Ciarlo L; Manganelli V; Matarrese P; Garofalo T; Tinari A; Gambardella L; Marconi M; Grasso M; Misasi R; Sorice M; Malorni W
J Lipid Res; 2012 Oct; 53(10):2057-2068. PubMed ID: 22773688
[TBL] [Abstract][Full Text] [Related]
14. Mitochondrial fission and cristae disruption increase the response of cell models of Huntington's disease to apoptotic stimuli.
Costa V; Giacomello M; Hudec R; Lopreiato R; Ermak G; Lim D; Malorni W; Davies KJ; Carafoli E; Scorrano L
EMBO Mol Med; 2010 Dec; 2(12):490-503. PubMed ID: 21069748
[TBL] [Abstract][Full Text] [Related]
15. ATAD3A oligomerization causes neurodegeneration by coupling mitochondrial fragmentation and bioenergetics defects.
Zhao Y; Sun X; Hu D; Prosdocimo DA; Hoppel C; Jain MK; Ramachandran R; Qi X
Nat Commun; 2019 Mar; 10(1):1371. PubMed ID: 30914652
[TBL] [Abstract][Full Text] [Related]
16. Impaired mitochondrial dynamics and Nrf2 signaling contribute to compromised responses to oxidative stress in striatal cells expressing full-length mutant huntingtin.
Jin YN; Yu YV; Gundemir S; Jo C; Cui M; Tieu K; Johnson GV
PLoS One; 2013; 8(3):e57932. PubMed ID: 23469253
[TBL] [Abstract][Full Text] [Related]
17. A novel Drp1 inhibitor diminishes aberrant mitochondrial fission and neurotoxicity.
Qi X; Qvit N; Su YC; Mochly-Rosen D
J Cell Sci; 2013 Feb; 126(Pt 3):789-802. PubMed ID: 23239023
[TBL] [Abstract][Full Text] [Related]
18. In silico identification of potential dynamin-related protein 1 antagonists: implications for diseases involving mitochondrial dysfunction.
Hanumanthappa P; Rajanikant GK
Comb Chem High Throughput Screen; 2014 Jan; 17(1):25-34. PubMed ID: 23848310
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of excessive mitochondrial fission reduced aberrant autophagy and neuronal damage caused by LRRK2 G2019S mutation.
Su YC; Qi X
Hum Mol Genet; 2013 Nov; 22(22):4545-61. PubMed ID: 23813973
[TBL] [Abstract][Full Text] [Related]
20. Interaction of mitochondrial fission factor with dynamin related protein 1 governs physiological mitochondrial function in vivo.
Kornfeld OS; Qvit N; Haileselassie B; Shamloo M; Bernardi P; Mochly-Rosen D
Sci Rep; 2018 Sep; 8(1):14034. PubMed ID: 30232469
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]